Injective (INJ) Sees Significant Daily Active Address Growth Amid Network Upgrades and Market Uncertainty

• Injective Network (INJ) experiences a remarkable 1,700% surge in daily active addresses in 2025, signaling heightened user engagement and network vitality.

• The spike follows the successful implementation of the Nivara Upgrade and the launch of Injective’s Ethereum Virtual Machine (EVM) testnet, enhancing developer activity and ecosystem growth.

• According to COINOTAG sources, despite INJ trading 80% below its all-time high, its expanding focus on real-world assets (RWA) and robust on-chain metrics suggest the token may be undervalued.

Injective Network’s daily active addresses soar 1,700% in 2025 post-Nivara Upgrade and EVM testnet launch, highlighting potential undervaluation amid growing RWA adoption.

Injective Network’s Daily Active Addresses Surge to New Heights in 2025

Injective Network (INJ) has demonstrated a significant rebound in user activity throughout 2025, with daily active addresses (DAAs) increasing from approximately 4,500 at the start of the year to over 81,000 by July. This represents a staggering 1,700% increase, marking the highest engagement level since December 2023.

This surge is closely linked to the deployment of the Nivara Upgrade on February 17, which enhanced network performance and scalability. The upgrade was met with strong community support, reflecting confidence in Injective’s roadmap. Additionally, the launch of the Ethereum Virtual Machine (EVM) public testnet on July 3 has attracted developers eager to build Ethereum-compatible decentralized applications (dApps) on Injective’s Layer 1 blockchain, further driving network activity.

Market analysts view this uptick in DAAs as a potential precursor to renewed price momentum, suggesting that Injective’s ecosystem is entering a phase of accelerated growth and adoption.

Technological Advancements Fuel Developer and User Engagement

The Nivara Upgrade introduced critical protocol improvements, including enhanced transaction throughput and reduced latency, which have made the network more attractive to both developers and users. The subsequent launch of the EVM testnet enables seamless integration with Ethereum-based tools and smart contracts, positioning Injective as a versatile platform for decentralized finance (DeFi) and tokenized asset applications.

Industry expert Lennaert Snyder remarked, “INJ daily active addresses pumped +1,500% to 82,500 in 6 months. Injective is growing exponentially and this is just the beginning.” This sentiment underscores the growing confidence in Injective’s technical foundation and ecosystem potential.

Evaluating Injective’s Market Position and Undervaluation Potential

Despite these positive developments, INJ’s market price remains approximately 80% below its all-time high of $52, currently trading near $10.5 as of mid-2025. This disconnect between on-chain activity and token price has led some investors to consider INJ undervalued, especially given the project’s accelerated token burn rate and deflationary mechanisms introduced with INJ 3.0.

Injective’s weekly protocol revenue burn has increased fivefold, effectively reducing circulating supply and applying deflationary pressure. However, the broader altcoin market conditions have constrained price recovery, despite robust fundamentals.

Real-World Asset Tokenization: A Strategic Growth Avenue

Injective’s strategic emphasis on tokenizing real-world assets (RWA) positions it uniquely within the Layer 1 blockchain landscape. As institutional and retail interest in tokenized stocks and assets intensifies, Injective’s infrastructure offers a scalable and interoperable solution for these emerging markets.

Investor CryptoBusy highlighted, “Injective INJ is massively underrated. Major devs, partners, and launches are lining up behind the scenes, preparing for a wave of product rollouts that could make everything to date look small.” This perspective reflects growing anticipation around Injective’s upcoming initiatives and partnerships.

Conclusion

Injective Network’s dramatic increase in daily active addresses, driven by strategic protocol upgrades and the EVM testnet launch, signals a revitalized ecosystem with strong developer and user engagement. Despite trading significantly below its all-time high, the network’s focus on real-world asset tokenization and deflationary tokenomics suggests that INJ may be undervalued relative to its growth potential. Investors and market participants should closely monitor Injective’s upcoming developments as it aims to solidify its position as a leading Layer 1 blockchain for tokenized assets.